drugset / Trial / NCT05823883
This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK) after administration of DW6014 and each component in healthy adult volunteers in fed condition.
Timeline
- Start
- 2023-06
- Primary completion
- 2023-07
- Completion
- 2023-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DW6014 | Unknown | — | Oral |
| Subject | Empagliflozin | Small molecule | — | Oral |
| Subject | Metformin | Small molecule | — | Oral |
Indications
No indication recorded.